We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NFX market cap is 709.65k. The company's latest EPS is GBP -0.0006 and P/E is -0.83.
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 610k | 535k | 196k | 50k | 0 |
Operating Income | -1.81M | -914k | -1.37M | -1.27M | -892k |
Net Income | -1.66M | -756k | -1.25M | -1.11M | -859k |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 4.64M | 5.13M | 6.01M | 4.98M | 4.42M |
Total Liabilities | 820k | 383k | 325k | 238k | 223k |
Total Equity | 3.82M | 4.74M | 5.69M | 4.74M | 4.2M |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -299k | -718k | -845k | -1.35M | -596k |
Investing | -27k | -43k | 43k | N/A | 50k |
Financing | -7k | 1.3M | 1.93M | 140k | 285k |
Market Cap | 709.65k |
Price to Earnings Ratio | -0.83 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5 |
Price to Book Ratio | 0.17 |
Dividend Yield | - |
Shares Outstanding | 1.42B |
Average Volume (1 week) | 6.8M |
Average Volume (1 Month) | 54.06M |
52 Week Change | -82.14% |
52 Week High | 0.44 |
52 Week Low | 0.04 |
Spread (Intraday) | 0.01 (18.18%) |
Company Name | Nuformix Plc |
Address |
6th floor london EC3V 0HR |
Website | https://www.nuformix.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions